Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Assessing Breast Cancer Neoadjuvant Therapy Response Using Imagio Opto-Acoustic Imaging

NCT05337280 is registered in ClinicalTrials.gov with Seno Medical Instruments Inc. as lead sponsor.

NCT NCT05337280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05337280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Assessing Breast Cancer Neoadjuvant Therapy Response Using Imagio Opto-Acoustic Imaging
Lead sponsor
Seno Medical Instruments Inc.
Phase
Not applicable
Overall status
Completed
Start date
March 30, 2021
Completion date
January 4, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer